cancer therapy | GenomeWeb

cancer therapy

The activity follows a recent financing round that has enabled OncoDNA to build out its sales team as it courts new clients.

The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.

Central Park, NYC

From targeted metagenomics on almost 300 soil samples, researchers saw evidence for microbiome gene clusters associated with natural product biosynthesis in NYC parks.

The partners will combine genome editing approaches with Watson's computational and machine learning methods to study drug-resistance in tumors.

The consortium aims to profile up to 800 multiple myeloma patient samples using the Affymetrix platform with a goal of developing a list of predictive biomarkers.

The researchers identified 122 potential immune response drivers that could serve as targets for drug research efforts.

The researchers identified new combinations of mutated genes and drugs that could provide the platform for future cancer therapies. 

Backed by $12 million from a recent Series A financing and a strategic partnership with Thermo Fisher Scientific, the Ann Arbor, Michigan-based firm plans to sequence the tumors of 100,000 advanced cancer patients over three years.

Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.

Elaine Mardis of Washington University in St. Louis described genome-guided efforts to identify neoantigen targets for cancer vaccines in melanoma and other cancer types.

Pages

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.